Stemcentrx

Stemcentrx

Stemcentrx

Stem CentRx develops therapies and diagnostics for cancer patients.
Founded
2008
Raised
$23.5M
Follow us
Alexa global traffic share
Twitter followers
Acquired by
AbbVie
4
28 Apr 2016
$5,800,000,000
Latest funding
$23,526,990
Venture capital - 2011
ARTIS Ventures Stuart Peterson
Xconomy

AbbVie Shares Plummet as $5.8B Bet on Stemcentrx Takes a Hit

Health
BI Tech

Here's the cancer data that led AbbVie to make the second-largest acquisition in the history of venture capital

Bloomberg Technology , TechCrunch

Stemcentrx Sale to Return a Record $1.7 Billion for VC Firm Founders Fund

Funding Health
$5,800,000,000
TechCrunch , Xconomy , BI Tech , +1

AbbVie acquiring cancer drug startup StemcenTrx for $5.8 billion

Health Funding Strategy
WSJD

Stemcentrx Pursues Strategic Alternatives, Including Sale

VentureWire

Peter Thiel-Backed Stemcentrx Emerges With $5 Billion Valuation

Health Funding Science
BI Tech

Peter Thiel backed this startup that wants to cure cancer, and it's worth $5 billion